Stay updated on Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.

Latest updates to the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page
- Check5 days agoChange DetectedA new version entry (41) was added on 2026-05-11 with a Study Status change and the tag Revision: v3.5.4. The earlier Revision: v3.5.3 was removed on 2026-02-06.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer revision indicator was updated from v3.5.2 to v3.5.3, reflecting a system/UI version change rather than altering the trial record details.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision v3.5.2 was added and Revision v3.5.0 was removed from the study history log. This appears to be a software/version update entry rather than a modification to trial data or core page content.SummaryDifference0.1%

- Check62 days agoChange DetectedThe record history now lists revision v3.5.0, replacing v3.4.3. It indicates a system update without changes to the study data or visible page content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision history updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedUpdates include a revision note (Revision: v3.4.2) and the addition of a 'Study Status' element in the History view; the underlying study data remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in ISN/RPS Class III/IV Lupus Nephritis Clinical Trial page.